Location History:
- Forest Gate, GB (1999)
- Fowlmere, GB (2008)
- Royston, GB (2004 - 2012)
Company Filing History:
4 out of 28 
2 out of 1,309 
1 out of 259 
Years Active: 1999-2012
Title: The Innovative Contributions of Andrew James Williams
Introduction: Andrew James Williams, a distinguished inventor based in Royston, GB, has made significant advancements in the field of biotechnology. With a total of 6 patents to his name, Williams has developed pioneering technologies that aim to address critical health challenges, particularly in immune response modulation and cancer treatment.
Latest Patents: Among his most recent innovations is the patent for "Nucleic acids coding for antibodies against human IL-21 receptor and uses therefor." This groundbreaking application presents human antibodies that specifically target the human interleukin-21 receptor (IL-21R), acting as antagonists to modulate immune responses. Such advancements have the potential to revolutionize therapies for inflammatory disorders, autoimmune diseases, allergies, transplant rejection, and cancer. Another notable patent involves "Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof." This patent provides specific binding members associated with the antibody NH576, which can play a critical role in both treatment and diagnosis of tumors.
Career Highlights: Andrew Williams has contributed his expertise to reputable organizations, including Cambridge Antibody Technology Limited and Wyeth. His work at these companies has been instrumental in fostering innovations that enhance therapeutic options in biotechnology.
Collaborations: Throughout his career, Williams has collaborated with esteemed professionals such as Philip Ronald Tempest and Kevin Stuart Johnson. These partnerships have enriched his research endeavors and contributed to the successful development of his patented technologies.
Conclusion: Andrew James Williams exemplifies the spirit of innovation within the biotechnology field. His patented inventions reflect a commitment to improving health outcomes through scientific advancement, making him a pivotal figure in current and future biomedical research. With ongoing work, he continues to inspire the next generation of inventors and researchers.